World Investment Advisors Lowers Position in Globe Life Inc. $GL

World Investment Advisors trimmed its position in Globe Life Inc. (NYSE:GL) by 47.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,075 shares of the company’s stock after selling 2,748 shares during the period. World Investment Advisors’ holdings in Globe Life were worth $382,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in GL. Global Assets Advisory LLC bought a new stake in shares of Globe Life during the 2nd quarter valued at $25,000. AdvisorNet Financial Inc boosted its stake in Globe Life by 60.0% during the second quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock worth $28,000 after acquiring an additional 84 shares in the last quarter. TD Private Client Wealth LLC purchased a new stake in Globe Life in the second quarter worth about $39,000. SouthState Corp bought a new position in shares of Globe Life during the first quarter valued at approximately $43,000. Finally, Ransom Advisory Ltd purchased a new position in shares of Globe Life during the first quarter valued at approximately $50,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on GL. Truist Financial upped their price target on Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a research note on Friday, October 24th. Wells Fargo & Company reduced their price target on Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a report on Friday, October 24th. BMO Capital Markets reaffirmed a “market perform” rating and issued a $149.00 price target (up previously from $114.00) on shares of Globe Life in a research report on Wednesday, July 30th. Morgan Stanley set a $179.00 price objective on shares of Globe Life and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Finally, Cfra Research upgraded shares of Globe Life to a “moderate buy” rating in a research note on Friday, July 25th. Eight analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $153.56.

Globe Life Trading Down 0.7%

Shares of NYSE:GL opened at $130.65 on Tuesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.06 and a quick ratio of 0.06. Globe Life Inc. has a 1 year low of $100.27 and a 1 year high of $147.83. The company has a market cap of $10.58 billion, a P/E ratio of 9.47 and a beta of 0.55. The stock’s fifty day moving average price is $138.80 and its 200-day moving average price is $130.17.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share for the quarter, topping analysts’ consensus estimates of $4.54 by $0.27. The business had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.52 billion. Globe Life had a return on equity of 22.12% and a net margin of 19.36%.During the same quarter in the previous year, the firm earned $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. Sell-side analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, October 3rd were given a dividend of $0.27 per share. The ex-dividend date was Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. Globe Life’s dividend payout ratio is 7.83%.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.